Turbine Simulated Cell Technologies

Turbine to Simulate Hard-to-Treat Cancer Populations with AI for Identification of Novel Dependencies through Collaboration with MSD Explore the future of cancer research with cell simulation technology, used by MSD-Discover how AI is transforming patient population.

We’re proud to share that Turbine is partnering with MSD (Merck & Co., Inc., Rahway NJ, USA) to unlock new possibilities in the fight against hard-to-treat cancers.

💥 Check out the full press release below for more details: turbine.ai/announcement...

Turbine on LinkedIn: #worldadc #worldadc The new era of ADC payload prediction starts now. Step inside the interactive tour of our digital lab next week for a peek behind the curtains! At Turbine…

www.linkedin.com/posts/turbin...

🚀 The new era of ADC payload prediction starts now. Step inside the interactive tour of our digital lab next week for a peek behind the curtains!

Turbine on LinkedIn: #worldadc #adcs #oncology #worldadc #turbine #drugdiscovery 💡 Why ADC development needs a game changer? The ADC landscape is booming, with the market projected to surpass $45 billion by 2030. But despite blockbuster…

www.linkedin.com/posts/turbin...

💡ADC development remains full of pitfalls: high failure rates persist ~820 inactive programs and ~110 discontinued, while unstable linkers pose risks, with off-target effects threatening precision.

Read the thoughts of Bernd Seizinger, an ADC expert and member of our Independent Board, to weigh in.